Monday, May 11, 2026

 

Invisible smart bug fights gum disease




KeAi Communications Co., Ltd.

How the engineered HEpM remodel the periodontal microenvironment. 

image: 

How the engineered HEpM remodel the periodontal microenvironment.

view more 

Credit: Lili Chen





Periodontitis—a chronic inflammatory disease that damages the gums and bones supporting teeth—affects nearly half of adults worldwide. Current treatments often fail because they cannot simultaneously eliminate stubborn bacterial biofilms and calm the runaway inflammation that follows.

Now, researchers have engineered a living bacterium that does both, in the right order.

In a study published in Dental Research, a team of researchers from China and Australi started with Escherichia coli Nissle 1917 (EcN), a harmless probiotic, and gave it three clever upgrades. First, they loaded it with nanoparticles containing metronidazole, an antibiotic that only becomes active in the oxygen‑free environment of a diseased gum pocket. Second, they equipped the bacterium with a hemoglobin from a bacterium that loves oxygen (Vitreoscilla). This "invisible cloak" protects the probiotic from its own antibiotic. Finally, they added a heat-sensitive genetic switch that turns on an antioxidant enzyme (superoxide dismutase) only when triggered by a mild warm stimulus.

"We wanted a therapy that respects the natural course of the disease—first clean up the harmful microbes, then resolve the inflammation," says senior and co-corresponding author Lili Chen. "Our design allows us to remotely activate the anti‑inflammatory phase precisely when the first job is done."

In a rat model of periodontitis, the two‑stage treatment dramatically reduced the key pathogens P. gingivalis and F. nucleatum and restored a healthy-like oral microbiome. After heat activation, the engineered bacteria lowered oxidative stress and promoted repair of the periodontal ligament and alveolar bone. Single-cell sequencing revealed that fibroblasts became the central hub of tissue‑regenerating signals.

"What if something goes wrong? To that end, we built in a fail‑safe: the same hemoglobin that acts as an 'invisible cloak' also serves as a natural sonosensitizer," shares Chen. "Additionally, we introduced a short, low‑energy ultrasound pulse (1 W/cm², 5 min), which safely lyses the engineered bacteria with no trace left behind."

"This is the first time a living bacterium has been programmed to execute a temporal, two‑step therapeutic program inside the body," says co-corresponding author Yuzhou Wu. "The platform could be adapted for other inflammatory diseases where microbial imbalance and oxidative stress play a role."

###

Contact the author: Lili Chen, Department of Stomatology, Union Hospital, Tongji Medical College, Hubei Province Key Laboratory of Oral and Maxillofacial Development and Regeneration, School of Stomatology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, P. R. China. E-mail: chenlili1030@hust.edu.cn.

The publisher KeAi was established by Elsevier and China Science Publishing & Media Ltd to unfold quality research globally. In 2013, our focus shifted to open access publishing. We now proudly publish more than 200 world-class, open access, English language journals, spanning all scientific disciplines. Many of these are titles we publish in partnership with prestigious societies and academic institutions, such as the National Natural Science Foundation of China (NSFC).

No comments: